
Johnson & Johnson was named in an ERISA class action on Feb. 5 in New Jersey federal court in a case filed by Wheeler, DiUlio & Barnabei and Fairmark Partners that accused the company and its pension and benefits committee of failing to prudently manage its prescription drug benefits plan.
February 08, 2024, 10:01 AM